HDACs inhibitors can enhance the clearance of Aβ from brain [40] by inducing expression of plasmin [12], inhibit the Aβ production and neuritic plaque formation [41], and reverse the contextual memory deficits in a mouse model of AD [42]. The gene discussed is PLG; the disease is Alzheimer disease.